Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

CIRTEK HOLDINGS LIMITED

常達控股有限公司

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 1433)

GRANT OF SHARE OPTIONS

This announcement is made pursuant to Rule 17.06A of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the "Listing Rules").

The board (the "Board") of directors (the "Directors") of Cirtek Holdings Limited (the "Company", together with its subsidiaries collectively, the "Group") hereby announces that on 15 September 2020 (the "Date of Grant"), the Company granted to one of our senior management (the "Grantee") entitled under the share option scheme adopted by the Company on 21 February 2020 (the "Share Option Scheme"), subject to his acceptance, share options (the "Share Options") carrying rights to subscribe for up to a total of 2,000,000 ordinary shares of the Company of HK$0.01 each (the "Shares") under the Share Option Scheme. Details of the Share Options granted are set out as follows:

Date of Grant

Total number of Shares which may be issued upon full exercise of the Share Options granted

  • 15 September 2020
  • 2,000,000 Shares

Exercise price of the Share

: HK$0.057 per Share, which is not less than the highest

Options granted

of:

  1. the closing price of HK$0.055 per Share as stated in the Stock Exchange's daily quotations sheet on the Date of Grant;

- 1 -

(ii)

the average closing price of HK$0.057 per Share as

stated in the Stock Exchange's daily quotations

sheets for the five business days immediately

preceding the Date of Grant; and

(iii)

the nominal value of HK$0.01 per Share on the Date

of Grant.

Vesting period of the

:

(i)

50% of the Share Options will be exercisable

Share Options

commencing from 31 December 2021; and

(ii)

the remaining 50% of the Share Options will be

exercisable commencing from 31 December 2023.

Closing price of the Shares

:

HK$0.055 per Share

on the Date of Grant

Validity period of the

: 5 (five) years from the Date of Grant (up to 14 September

Share Options

2025)

The Grantee is not a director, a chief executive or a substantial shareholder (within the meaning as ascribed to it under the Listing Rules) of the Company, or any of their respective associates (within the meaning as ascribed to it under the Listing Rules).

For and on behalf of the Board

Cirtek Holdings Limited

CHAN Sing Ming Barry

Chairman and Executive Director

Hong Kong, 15 September 2020

As at the date of this announcement, the Board comprises Mr. Chan Sing Ming Barry, Ms. Law Miu Lan and Mr. Chan Tsz Fung being executive Directors; and Mr. Lam Chor Ki Dick, Mr. Lee Tak Cheong and Dr. Wong Chi Wing being independent non-executive Directors.

- 2 -

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original document
  • Permalink

Disclaimer

Cirtek Holdings Ltd. published this content on 15 September 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 15 September 2020 12:29:09 UTC